The Protective Effect of the Recombinant 53-kDa Protein of Trichinella spiralis on Experimental Colitis in Mice
- 8 April 2011
- journal article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 56 (10), 2810-2817
- https://doi.org/10.1007/s10620-011-1689-8
Abstract
Helminth infection has been proven to reduce the severity of experimental inflammatory bowel disease (IBD). The excretory-secretory proteins of helminths play an important role in the process of immunomodulation. In the present study, we aimed to investigate the protective potential of recombinant Trichinella spiralis (TS) 53-kDa protein (rTsP53), a component of excretory-secretory proteins, on experimental colitis in mice. BALB/c mice were treated subcutaneously with 50 μg rTsP53 three times at an interval of 5 days. Colitis was induced by intrarectal administration of 5 mg trinitrobenzene sulfonic acid (TNBS). Disease activities and macroscopic and microscopic scores were evaluated. To determine immune response provoked by rTsP53, we measured specific IgG1 and IgG2a values against rTsP53 in sera of mice. We also detected cytokine profiles as well as the markers of alternatively activated macrophages (M2) in mice. RTsP53 ameliorated significantly the disease activity index (DAI) as well as the macroscopic and microscopic scores. IgG1 but not IgG2a was the predominant specific antibody detected in the sera of immunized mice, indicating the potential of stimulating T-helper (Th) 2 bias response by rTsP3. Pre-treatment with rTsP53 decreased serum Th1 cytokines (TNF-a, IFN-γ) and elevated serum levels of serum Th2 cytokines (IL-4, IL-13); it also decreased colonic Th1 cytokines (TNF-α, IL-6) and colonic regulatory cytokines (IL-10, TGF-β1). RTsP53 increased colonic M2 markers, arginase-1 (Arg-1), and found in inflammatory zone 1 (FIZZ1), compared to mice without rTsP53 pretreatment. RTsP53 is a potential protective agent for IBD.Keywords
This publication has 34 references indexed in Scilit:
- Model of colonic inflammation: Immune modulatory mechanisms in inflammatory bowel diseaseJournal of Theoretical Biology, 2010
- Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular componentBiomaterials, 2009
- Helminth antigen-based strategy to ameliorate inflammation in an experimental model of colitisClinical and Experimental Immunology, 2008
- Species-Specific Antibody Responses to the Recombinant 53-Kilodalton Excretory and Secretory Proteins in Mice Infected withTrichinellasppClinical and Vaccine Immunology, 2008
- Helminth Infection Enhances Disease in a Murine TH2 Model of ColitisGastroenterology, 2007
- Characterization of the immuno-regulatory response to the tapeworm Hymenolepis diminuta in the non-permissive mouse hostInternational Journal for Parasitology, 2007
- Memory TH2 cells induce alternatively activated macrophages to mediate protection against nematode parasitesNature Medicine, 2006
- Development and Evaluation of a Western Blot Kit for Diagnosis of Human TrichinellosisClinical and Vaccine Immunology, 2003
- Childhood infections and the risk of inflammatory bowel diseaseDigestive Diseases and Sciences, 1994
- Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cellsImmunology Today, 1994